info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_PIRIFORMSINUS_EXALLC for full statistics.

Malignant neoplasm of pyriform sinus

C3_PIRIFORMSINUS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C12&
  • Cause of death: ICD-9 1481A
  • Cause of death: ICD-8 1481
  • Cancer registry: Topography ICD-O-3 C12
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

21

4. Check minimum number of events

None

21

5. Include endpoints

None

21

6. Filter based on genotype QC (FinnGen only)

21

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9

Similar endpoints

List of similar endpoints to Malignant neoplasm of pyriform sinus based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 21 - 19
Unadjusted period prevalence (%) 0.01 - 0.01
Median age at first event (years) 69.51 - 69.86

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
13
32
8.91
5.13
8.2
3.2
mmol/l
0.7
0.8
1.10
13
32
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
11
10.90
4.32
1.6
1.1
—
—
—
0
0
(4035726)
9
19
7.43
3.76
1.6
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
11
8.88
3.51
1.6
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
9
8.77
3.09
2.0
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
27
5.03
2.82
2.2
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
0
58
0.00
2.57
0.0
3.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
12
50
4.23
2.52
4.4
2.4
u/l
51.4
62.9
0.66
12
45
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
8
7.75
2.51
2.2
5.8
mmol/l
26.0
25.0
—
5
8
(40758558) Short blood count panel - Blood
10
42
3.64
2.05
13.9
8.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
12
57
3.56
1.99
4.3
4.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
14
79
3.30
1.75
5.9
5.8
mmol/l
1.2
1.2
0.07
14
72
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
14
84
2.99
1.67
8.6
8.6
mmol/l
1.2
1.2
0.29
14
76
(3033658) Prothrombin time (PT) actual/Normal
9
41
3.07
1.64
6.4
3.3
%
76.9
85.1
—
9
41
(3014576) Chloride [Moles/volume] in Serum or Plasma
6
22
3.39
1.56
1.8
4.7
mmol/l
103.7
103.2
—
6
22
(40768804) Tissue Pathology biopsy report
12
67
2.83
1.54
4.1
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
13
77
2.79
1.48
7.2
10.1
—
1.3
—
0
18
(3003694) ABO and Rh group [Type] in Blood
8
40
2.60
1.30
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
26
2.81
1.29
1.3
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
20
2.95
1.22
2.4
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.95
1.22
2.2
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
8
42
2.45
1.05
3.0
2.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6
31
2.30
0.93
1.5
1.8
s
28.2
29.1
—
6
31
(3019309) Folate [Moles/volume] in Red Blood Cells
7
39
2.18
0.83
1.7
1.6
nmol/l
523.3
1142.6
—
7
33
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
23
2.53
0.83
2.2
4.0
%
29.8
30.8
—
5
14
(3013512) EKG study
8
51
1.91
0.72
6.4
4.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
8
51
1.91
0.72
3.6
5.6
—
7.4
—
0
6
(42870588) Differential panel, method unspecified - Blood
9
60
1.87
0.68
9.8
5.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
22
0.00
0.63
0.0
3.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
10
70
1.82
0.55
2.7
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
8
55
1.73
0.52
3.1
2.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
8
56
1.69
0.51
3.1
3.5
umol/l
316.9
386.0
—
8
50
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
13
105
1.62
0.44
3.8
2.7
u/l
72.6
51.6
0.29
13
95
(40761536) Microorganisms panel - Urine sediment
0
15
0.00
0.43
0.0
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
15
0.00
0.43
0.0
1.7
—
—
—
0
0
(4010399)
0
17
0.00
0.42
0.0
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
40
1.70
0.41
1.7
3.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
11
132
0.65
0.32
4.0
4.5
ug/l
1.2
1.9
1.51
11
113
(3044889) 12 lead EKG panel
11
129
0.69
0.25
4.5
4.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
11
0.00
0.22
0.0
1.9
—
263.0
—
0
11
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
11
0.00
0.22
0.0
3.6
—
0.2
—
0
11
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3015736) pH of Urine
7
60
1.25
0.21
1.6
3.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
14
0.00
0.21
0.0
1.9
—
41.4
—
0
14
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
10
85
1.34
0.16
2.6
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
5
44
1.18
0.11
1.6
2.7
e6/l
2.2
3.5
—
5
38
(3009508) Creatinine [Moles/volume] in Urine
6
56
1.10
0.10
2.0
3.3
mmol/l
6.6
8.3
—
6
47
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
59
0.80
0.10
1.6
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
9
80
1.22
0.09
2.4
4.6
—
0.0
—
0
16
(3035350) Ketones [Presence] in Urine by Test strip
9
82
1.17
0.09
1.7
3.5
—
0.0
—
0
18
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
103
1.14
0.02
3.5
4.4
%
29.6
20.1
—
5
48
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
3.8
—
4.0
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
8
82
0.96
0.00
1.6
3.5
—
0.0
—
0
14
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
12.2
—
0
5
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(1002224) Polysomnography panel
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
3.5
—
1.2
—
0
6
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
4.2
—
0
7
(3039443) Prostate specific Ag panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
30.9
—
0
8
(3019832) Treponema pallidum Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_PIRIFORMSINUS – Malignant neoplasm of pyriform sinus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).